Merck & Co. (MRK) stock lost over 9% yesterday on announcing a temporary shipment halt of its Gardasil vaccine to China. The ...

Merck (MRK) stock was mangled today after the pharmaceutical and vaccine company released its guidance for 2025. The company expects adjusted ...

Merck (MRK) shares drop 8% premarket as 2025 outlook falls short of Wall Street estimates, despite beating Q4 expectations ...

Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset ...

Merck shares tumbled Tuesday morning after the drugmaker's soft outlook outweighed fourth-quarter revenue and adjusted profits topping expectations.

In this article, we are going to take a look at where Merck KGaA (OTC:MKGAF ... as tensions in the tech sector subsided. European stock pickers are exploring established sectors such as utilities ...

In this article, we are going to take a look at where Merck KGaA (OTC:MKGAF) stands against Morgan ... and utilities stocks as tensions in the tech sector subsided. European stock pickers are ...

Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded. [Operator instructions] I would now like to turn the call over to Mr. Peter ...

KWS SAAT SE KGaA (ETR:KWS) has had a rough three months ... Earnings growth is an important metric to consider when valuing a stock. The investor should try to establish if the expected growth ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...